Skip to main content
. 2020 Apr;10(2):325–335. doi: 10.21037/cdt.2019.05.03

Figure 5.

Figure 5

The wearable cardioverter-defibrillator (WCD) is a non-invasive device that is worn by patients with LVEF <35%. The WCD is able to deliver biphasic shocks when a life-threatening arrhythmia is detected and could be used as a ‘bridging’ strategy during the first 6 months of vulnerability to sudden cardiac death in PPCM, before a final decision towards implantable cardioverter-defibrillator (ICD) is made. PPCM, peripartum cardiomyopathy; LVEF, left ventricular ejection fraction.